Form 8-K - Current report:
SEC Accession No. 0000939767-22-000121
Filing Date
2022-12-15
Accepted
2022-12-15 17:17:06
Documents
13
Period of Report
2022-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K exel-20221215.htm   iXBRL 8-K 31784
5 exel-20221215_g1.jpg GRAPHIC 116418
  Complete submission text file 0000939767-22-000121.txt   433046

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20221215.xsd EX-101.SCH 1915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20221215_lab.xml EX-101.LAB 26135
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20221215_pre.xml EX-101.PRE 13590
7 EXTRACTED XBRL INSTANCE DOCUMENT exel-20221215_htm.xml XML 11669
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 221465685
SIC: 2836 Biological Products, (No Diagnostic Substances)